(VIANEWS) – The NASDAQ ended the session with 10x Genomics (TXG) jumping 5.37% to $143.45 on Friday while NASDAQ Composite rose 0.39% to $15,239.53.
Today’s last reported volume for 10x Genomics is 768112, 12.25% above its average volume of 684249.
10x Genomics’s last close was $136.14, 34.86% under its 52-week high of $208.99.
10x Genomics’s Sales
10x Genomics’s sales growth is 78.1% for the current quarter and 33.2% for the next. The company’s growth estimates for the current quarter and the next is 70.8% and 97.2%, respectively.
10x Genomics’s Revenue
Year-on-year quarterly revenue growth grew by 170%, now sitting on 405.7M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
10x Genomics’s stock is considered to be overbought (>=80).
10x Genomics’s Stock Yearly Top and Bottom Value
10x Genomics’s stock is valued at $143.45 at 17:10 EST, way under its 52-week high of $208.99 and way above its 52-week low of $128.15.
10x Genomics’s Moving Average
10x Genomics’s worth is under its 50-day moving average of $155.93 and way under its 200-day moving average of $170.12.
More news about 10x Genomics (TXG).